<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08437015992778</udiDi>
    <basicUdiDi>B-08437015992778</basicUdiDi>
    <tradeName>Supralon 2%</tradeName>
    <deviceName>Supralon</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:53:10.525Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992761</udiDi>
    <basicUdiDi>B-08437015992761</basicUdiDi>
    <tradeName>Supralon 1,4%</tradeName>
    <deviceName>Supralon</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:53:09.551Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992327</udiDi>
    <basicUdiDi>B-08437015992327</basicUdiDi>
    <tradeName>OpHLINE 3.0%</tradeName>
    <deviceName>OpHLINE</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:53:08.759Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992310</udiDi>
    <basicUdiDi>B-08437015992310</basicUdiDi>
    <tradeName>OpHLINE 2.0%</tradeName>
    <deviceName>OpHLINE</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:53:04.756Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992303</udiDi>
    <basicUdiDi>B-08437015992303</basicUdiDi>
    <tradeName>OpHLINE 1.4%</tradeName>
    <deviceName>OpHLINE</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:53:03.956Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992174</udiDi>
    <basicUdiDi>B-08437015992174</basicUdiDi>
    <tradeName>DayDrop 20ud x 0.4ml</tradeName>
    <deviceName>DayDrop</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PV00047</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:53:03.188Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992167</udiDi>
    <basicUdiDi>B-08437015992167</basicUdiDi>
    <tradeName>DayDrop 15ud x 0.4ml</tradeName>
    <deviceName>DayDrop</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PV00046</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:53:02.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992150</udiDi>
    <basicUdiDi>B-08437015992150</basicUdiDi>
    <tradeName>DayDrop 5ud x 0.4ml</tradeName>
    <deviceName>DayDrop</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PV00045</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:52:58.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992105</udiDi>
    <basicUdiDi>B-08437015992105</basicUdiDi>
    <tradeName>DayDrop 30ud x 0.4ml</tradeName>
    <deviceName>DayDrop</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PV00040</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:52:57.553Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992051</udiDi>
    <basicUdiDi>B-08437015992051</basicUdiDi>
    <tradeName>OpHLINE 3.0%</tradeName>
    <deviceName>OpHLINE</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PV00006</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:52:56.755Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992143</udiDi>
    <basicUdiDi>B-08437015992143</basicUdiDi>
    <tradeName>Profilm Aftas Bucales (5ml)</tradeName>
    <deviceName>Profilm Aftas Bucales</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M04040501</emdnCode>
    <emdnDescription>HYDROGEL DRESSINGS, NON-COMBINED</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PV00071</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:52:55.959Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992044</udiDi>
    <basicUdiDi>B-08437015992044</basicUdiDi>
    <tradeName>OpHLINE 2.0%</tradeName>
    <deviceName>OpHLINE</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PV00004</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:52:40.695Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992037</udiDi>
    <basicUdiDi>B-08437015992037</basicUdiDi>
    <tradeName>OpHLINE 1.4%</tradeName>
    <deviceName>OpHLINE</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PV00002</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:52:38.295Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436630990077</udiDi>
    <basicUdiDi>8437015992UI0086G</basicUdiDi>
    <tradeName>Profilm Aphtes (5mL)</tradeName>
    <deviceName>Hidrogel para el tratamiento de heridas internas (AFTA1) / Hydrogel for the treatment of internal wounds (AFTA1)</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M04040501</emdnCode>
    <emdnDescription>HYDROGEL DRESSINGS, NON-COMBINED</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-03T12:01:44.245Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436630990053</udiDi>
    <basicUdiDi>8437015992UE0065G</basicUdiDi>
    <tradeName>Profilm Boutons de Fièvre</tradeName>
    <deviceName>Hidrogel para el tratamiento de heridas externas (HERP1) / Hydrogel for the treatment of external wounds (HERP1)</deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M04040501</emdnCode>
    <emdnDescription>HYDROGEL DRESSINGS, NON-COMBINED</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-03T12:01:43.451Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437015992112</udiDi>
    <basicUdiDi>8437015992UE0065G</basicUdiDi>
    <tradeName>Profilm Herpes Labial 5mL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M04040501</emdnCode>
    <emdnDescription>HYDROGEL DRESSINGS, NON-COMBINED</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-30T22:19:57.081Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437027750397</udiDi>
    <basicUdiDi>B-08437027750397</basicUdiDi>
    <tradeName>08437027750397</tradeName>
    <deviceName></deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:37:23.300Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437027750052</udiDi>
    <basicUdiDi>B-08437027750052</basicUdiDi>
    <tradeName>FILLAH HYDRA 1,4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:37:22.089Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437027750045</udiDi>
    <basicUdiDi>B-08437027750045</basicUdiDi>
    <tradeName>08437027750045</tradeName>
    <deviceName></deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:37:20.879Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437027750038</udiDi>
    <basicUdiDi>B-08437027750038</basicUdiDi>
    <tradeName>08437027750038</tradeName>
    <deviceName></deviceName>
    <manufacturerName>i+Med S.Coop.</manufacturerName>
    <manufacturerSrn>ES-MF-000008633</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:37:14.879Z</lastUpdated>
  </row>
</eudamedExport>